
Doximity (DOCS) Stock Forecast & Price Target
Doximity (DOCS) Analyst Ratings
Bulls say
Doximity has experienced significant growth in its point-of-care (POC) and formulary offerings, which expanded by over 100% during the recent buying season, indicating strong demand for its services among medical professionals. The company's stock has shown resilience and upward movement, with a 3.2% increase since September 8, suggesting positive market sentiment following the recent Memorandum. Additionally, the achievable and potentially favorable 2Q guidance, coupled with increased visibility from expanded offerings, positions Doximity for continued success in the evolving healthcare landscape.
Bears say
Doximity Inc. is facing a challenging financial outlook due to downward guidance revisions from its pharmaceutical clients, attributed to the current uncertain economic environment. The company's shares are perceived as expensive compared to its software peers, raising concerns about potential volatility if the financial results fall short of investor expectations. Additionally, there is significant pressure on Doximity to provide positive performance metrics, as any failure to exceed or raise guidance may lead to negative market reaction.
This aggregate rating is based on analysts' research of Doximity and is not a guaranteed prediction by Public.com or investment advice.
Doximity (DOCS) Analyst Forecast & Price Prediction
Start investing in Doximity (DOCS)
Order type
Buy in
Order amount
Est. shares
0 shares